The training group was divided into four subgroups (ANO1−/MMP3−, ANO1+/MMP3−, ANO1−/MMP3+, and ANO1+/MMP3+) based on the expression status of ANO1 and MMP3 in ESCC tumor tissues. This evidence concerns the gene ANO1 and esophageal squamous cell carcinoma.